Loading people...
Michal Silverberg is the Managing Director at the Novartis Venture Fund, based in Cambridge, Massachusetts. Over a 25-year career in the life sciences sector, she previously served as a Senior Partner at Takeda Ventures and held strategic business development and new product commercialization roles at Novo Nordisk. Her earlier professional experience includes positions at OSI Pharmaceuticals, the Office of the Chief Scientist of Israel, and Ofer Brothers Hi Tech VC. She holds a bachelor's degree in economics from Haifa University, an MBA from Tel Aviv University, and a master's degree in biotechnology from Columbia University. Her investment portfolio includes board directorships at Averna Therapeutics, GentiBio, and ONL Therapeutics, alongside notable exits such as the Adicet Bio and Forma Therapeutics initial public offerings. Silverberg currently focuses on early-stage venture capital funding to advance innovative biotechnology and pharmaceutical therapies.
Michal Silverberg is Managing Director at Novartis Venture Fund, based in Boston, MA, USA.
